New blood test could replace scans for HPV cancer patients
NCT ID NCT06640283
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a simple blood test that looks for tumor DNA from HPV-related cervical and anal cancers after radiation treatment. The goal is to see if this test can replace expensive imaging scans and help doctors find early signs of cancer returning. If the test is positive, patients may get immunotherapy early to try to improve outcomes. The trial involves 150 adults in Brazil and aims to make the test affordable for public healthcare.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAL CANAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Instituto do Câncer do Estado de São Paulo - ICESP
RECRUITINGSão Paulo, 01246-000, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can PET/CT scans improve Follow-Up for anal cancer patients?
- New drug YH32364 targets Hard-to-Treat cancers in first human trial
- Tailored radiation beams aim to outsmart aggressive throat cancer
- Skin-Saving paste for cancer radiation falls short in tiny trial
- Pee instead of swab: new study tests urine HPV test for cervical cancer
- Could a common painkiller combo ease cancer treatment pain?